Focus on Pretreatment Factors that possible effect to survival Pretreatment factors,
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Non small cell lung cancer who the oncologists consider receive treatment 2. Age ≥ 18 years 3. Definite diagnosis of NSCLC by histology, or cytology 4. Complete of laboratory investigation within1 week before starting chemotherapy 5. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
Exclusion criteria
Exclusion criteria: Previous treatment of chemotherapy or chemo radiotherapy 2. Patients who have NSCLC as a new second primary cancer. 3. Patients who have history of any infection within 2 weeks before chemotherapy 4. Patients who have history of chronic liver disease,or autoimmune disease 9
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| event 3 years retrospective data survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression symptom score baseline, week4 and week12 HRDS score/ clinician rated,urine 8-isoprostane baseline, week4 and week12 EIA kit/ mg,urine melatonin baseline, week4 and week12 EIA kit/ mg,adverse event baseline, week4 and week12 Adverse effects symptom check list /self-rated . | — |
Countries
Thailand
Contacts
Police Geneal Hospital